About Us
Drs. VK Gadi and Andrei Shustov, two world reknowned cancer researchers and physicians, noticed a trend – innovations in lifescience technology and biotechnology, formulated from great science, are not brought to market. Some of these innovations begin the commercialization tract but often end up as distressed assets and fail.
Conversations with other colleagues, who saw the same common theme and share a common vision, like any great innovations, outlining the structure on a napkin, a company was formed in 2017.
3rdEyeBio, LLC brings together experts with diverse backgrounds in science, strategy, investor relations, legal and marketing.
3rdEyeBio turns undervalued/undiscovered assets:
•into viable products •ready for commercialization – “right the ship”
•in the hands of providers faster
•improve patients access to better therapies
•improve patient outcomes
We do this by:
•Leveraging our large spheres of influence to validate the science •Active in both pre-clinical and clinical research and development
•Active management of strategy, finance, investor relations; ensuring capital efficiency
•Capital investment and 3rd party capital investment deals